Multivitamins, Mineral Blends and the "Brain Supplement" Marketing

The market for branded ADHD supplements has grown rapidly. The category sits in a regulatory grey area in the UK: food supplements are not required to demonstrate efficacy in the way that medicines are, and the language used to promote them is carefully crafted to imply treatment effects without making the explicit medicinal claims that would trigger MHRA regulation. This piece sets out the recurring marketing patterns, what the actual evidence on common ingredients shows, and the questions worth asking before buying.

How the market is structured

UK regulation distinguishes between medicines and food supplements ^{[3, 4]}:

• Medicines are regulated by the MHRA and must demonstrate efficacy through clinical trials before being licensed. Claims must be supported by evidence; the label specifies indications, dose, contraindications and side effects.
• Food supplements are regulated under food law. They cannot legally make medicinal claims. They can make limited health claims, but only those authorised by the Food Standards Agency or pre-authorised at EU level (some of which the UK has retained).

The "brain supplement" market sits firmly in the food supplement category. Products cannot legally say "treats ADHD". They can say "supports focus", "promotes mental clarity", "may help with attention", "formulated for the busy brain". These phrases are deliberately written to imply treatment effect without making the specific claim that would require evidence to a medicines standard.

This is not by itself a problem. Many food supplements are reasonable, safe, and useful in specific deficiency contexts. The issue is the way the language is used to imply something the regulator would not permit if asserted directly, and the way the price point is set on the implied treatment claim.

The recurring marketing patterns

Six patterns appear repeatedly. Worth being able to recognise:

"Doctor formulated" or "developed by a neuroscientist". Sometimes accurate, sometimes window dressing. Neither claim is the same as published randomised controlled trial evidence on the specific product. A product can be formulated by a qualified clinician on the basis of their preferences and theories without ever being tested in a trial. Where a product has published RCT evidence specifically, the manufacturer will say so explicitly; where it does not, the "doctor formulated" framing is often a substitute.

Reference to a small underpowered study on a single ingredient. The product contains ten ingredients; the marketing references a trial on one of them with thirty participants, an unblinded design, and an effect size that did not replicate elsewhere. The implication is that the product is evidence-based; the actual evidence is only on one ingredient in the mix and is methodologically weak.

Ingredient-stacking. A small piece of real evidence (say, omega-3 in ADHD, modest effect) gets bundled with several other ingredients of unknown ADHD relevance (bacopa, ginkgo, L-theanine, lion's mane), packaged together, and sold at a substantial markup over a basic single-ingredient supplement. The combination has no specific trial evidence behind it; the individual ingredients have varying levels of separate evidence, mostly weak.

Personalised quizzes leading to "your ADHD blend". Online questionnaires collect information about your sleep, mood, focus and energy, then recommend a custom supplement. The personalisation is largely cosmetic; the underlying product is one of a small set of pre-formulated blends. The quiz is a marketing tool rather than a clinical assessment.

"Natural alternative to stimulants". Frames the choice as harsh-prescription-medication versus natural-and-safe. Trades on parental anxiety about ADHD medication. In the few head-to-head comparisons that exist, licensed stimulants substantially outperform the natural alternatives.

Subscription and influencer marketing. TikTok and Instagram promotion to a target audience of recently-diagnosed adults and parents of recently-diagnosed children. Influencer testimonials are not evidence; subscription models maximise revenue from a customer who would otherwise stop buying after a few weeks.

The ingredients you will actually see

Common ingredients in branded ADHD blends, with honest evidence statements:

• Omega-3 fatty acids. Real but small ADHD evidence. Covered in omega-3 for ADHD. Better bought as a standalone fish oil than as part of a blend.
• Iron, zinc, magnesium, vitamin D. Real evidence only in deficiency states. Covered in iron and ferritin, zinc and magnesium, vitamin D. Routine inclusion in a non-deficient person does not produce benefit.
• L-theanine. Amino acid found in tea. Some evidence for sleep onset and anxiety reduction; no clinical evidence for ADHD treatment.
• L-tyrosine. Precursor in catecholamine synthesis. Theoretical relevance to dopamine; no strong clinical evidence in ADHD.
• Bacopa monnieri. Ayurvedic herb. Some evidence for cognitive support in older adults; very limited paediatric ADHD evidence; not first-line.
• Ginkgo biloba. Modest evidence for cognition in older adults with mild impairment; no clear ADHD-specific benefit; bleeding interaction with anticoagulants.
• Pycnogenol (French maritime pine bark extract). Trebatická 2006 paediatric ADHD RCT showed effect on attention measures ^[1]. Small, single trial. Some replication, mostly limited. Not in routine clinical guidance.
• Saffron extract. Small but real RCT evidence; covered in saffron for ADHD.
• Phosphatidylserine, choline, lion's mane, ashwagandha, ginseng. No strong clinical evidence in ADHD specifically. Some have other documented effects unrelated to ADHD.

The honest assessment: ingredients with real ADHD evidence (omega-3, iron in deficiency, saffron in some trials) are worth considering individually, in standardised preparations, under clinical or pharmacist guidance. The bundled product is rarely the right tool; if any one of those ingredients is the right intervention for you, buying it directly costs less and lets you adjust the dose.

Questions worth asking before buying

A useful five-question filter:

1. Is there a published RCT on this specific product (not just the ingredient class)? If yes, read it. If no, the marketing is using ingredient-class evidence to sell a different product.
2. What does the regulator actually permit the product to say? Phrases like "supports focus" indicate food-supplement framing, not licensed treatment.
3. What is the cost compared with buying the active ingredient as a standalone supplement? Often substantially higher.
4. What ingredients are in the blend that I cannot find evidence for? Marketing typically focuses on the one ingredient with evidence; the others ride along.
5. What does my prescribing clinician or pharmacist think? The right person to ask. Many UK community pharmacists are willing to give honest advice on supplement value.

What this means in practice

• The UK food supplement market sits in a regulatory framework that does not require efficacy evidence and does not permit medicinal claims. Marketing language is deliberately written to imply treatment effects without making explicit claims that would trigger medicines regulation.
• Six recurring patterns: "doctor formulated" replacing trial evidence; reference to small underpowered single-ingredient studies; ingredient-stacking around one real-evidence component; personalised-quiz marketing; "natural alternative to stimulants" framing; influencer and subscription distribution.
• Most ingredients in branded ADHD blends do not have strong trial evidence. The few with real evidence (omega-3, iron in deficiency, saffron in some trials) are usually better bought as standalone supplements at lower cost.
• Five questions to ask: product-specific RCT, regulatory category, cost-comparison, evidence-free ingredients, pharmacist or clinician opinion.
• The Faraone 2021 consensus does not recommend bundled supplement products as ADHD treatment.

When to speak to a professional

If you are considering a branded ADHD supplement for yourself or your child, the pharmacist is the most accessible source of practical UK advice; the GP and any prescribing clinician should be told what is being taken regardless. Where a deficiency is the question, blood testing first is the right step. NeuroFX adult ADHD assessment and child ADHD assessment include review of current supplements alongside the wider clinical picture; the team can advise on interactions with prescribed medication and where the supplement spend is or is not worth the money.

Sources

1. Trebatická J, Kopasová S, Hradečná Z, et al. Treatment of ADHD with French maritime pine bark extract, Pycnogenol. European Child and Adolescent Psychiatry. 2006;15(6):329-335.
2. Sonuga-Barke EJ, Brandeis D, Cortese S, et al. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. American Journal of Psychiatry. 2013;170(3):275-289.
3. MHRA. Borderline products. https://www.gov.uk/government/publications/borderline-products
4. Advertising Standards Authority (ASA). Supplements: medicinal claims. https://www.asa.org.uk/
5. Faraone SV, Banaschewski T, Coghill D, et al. The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neuroscience and Biobehavioral Reviews. 2021;128:789-818.
6. NHS. Vitamins and minerals. https://www.nhs.uk/conditions/vitamins-and-minerals/